A pooled analysis of 18 randomized trials has allowed researchers to unravel the so-called “smoker’s paradox,” proving that lighting up is an important risk factor for adverse events after PCI.

Analyzing the hearts of chimpanzees and gorillas offered insight into why human hearts evolved as they did in a recent study out of Harvard, the New York Times reports.

Urine flow rate-guided hydration, as opposed to left ventricular end-diastolic pressure-guided hydration, could prevent more complications in CKD patients who are at a high risk for contrast-induced kidney injury.

The CDC released updated statistics and a new framework for identifying, diagnosing and treating e-cigarette or vaping-related lung disease Oct. 11, putting a name to the recent phenomenon in the process.

A study published just two months after the FDA issued a statement acknowledging a late mortality signal with paclitaxel-coated and -eluting stents and balloons suggests the devices are actually safe in patients with lower extremity artery disease.

The Centers for Disease Control and Prevention doubled down on its warnings about vaping products Oct. 3 after new numbers revealed more than 1,000 reports of vaping-related lung illness and 18 fatalities in recent weeks.

Transient endothelial dysfunction stemming from mental duress was associated with a 78% increase in the incidence of MACE in a study of patients with stable CAD, providing scientists with a look at just how much psychological stress can influence our risk of CVD.

A poll conducted by researchers at Fairleigh Dickinson University in New Jersey has revealed that a quarter of Americans take daily low-dose aspirin at some point in their lives, but the majority of those people don’t have heart disease or another chronic illness.